Depression, schizophrenia and other mental health conditions affect 1 in 4 people in their lifetime, but the mechanisms ...

Neurocrine has commenced a Phase III registrational programme to assess NBI-1117568 as a treatment for schizophrenia in adult ...

New research reveals that immune system activity may play a causal role in conditions like schizophrenia, depression, and ...

A study reveals that immune system proteins play a role in mental health conditions such as depression, schizophrenia and ...

Depression, schizophrenia and other mental health conditions affect 1 in 4 people in their lifetime, but mechanisms underlying these conditions are poorly understood. New research has linked the ...

Schizophrenia drug Cobenfy, a key component in Bristol Myers Squibb’s plan to navigate a transition period of major loss of ...

Mount Sinai researchers have identified for the first time the neural mechanisms in the brain that regulate both positive and ...

By studying mutations in a gene called neurexin-1, which is highly associated with both schizophrenia and autism, researchers ...

Are substance-induced psychosis and primary psychosis fundamentally different? And if they are, does it matter?